MedPath
NMPA Approval

Methotrexate Injection

国药准字HJ20140207

July 28, 2023

H20140207

Drug Information

甲氨蝶呤注射液

注射剂

1000mg/10ml

化学药品

July 28, 2023

July 27, 2028

Company Information

Applicant Company

Level 17 151 Clarence Street Sydney NSW 2000 AUSTRALIA

Manufacturing Company

pfizer (perth) pty limited

Technology Park 15 Brodie Hall Drive BENTLEY WA 6102, Australia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲氨蝶呤注射液 - NMPA 批准文号 | MedPath